MARATTO

article · The Egyptian Journal of Hospital Medicine

Evaluation of Topical Hydrogen Peroxide 30% versus Topical Zinc Sulphate 10% in Treatment of Plane Warts: Clinical and Dermoscopic Study

Abstract

Background: Plane warts are caused by infection with human papilloma virus (HPV). Lesion usually presented as 2-4 mm flat topped papules, which are slightly erythematous or brown on pale skin and hypopigmented on darker skin. Many modalities of treatment were used, but none is uniformly effective. Objectives: To assess the efficacy and safety of topical hydrogen peroxide (HP) 30% versus topical zinc sulphate (ZnSO4) 10% in plane warts treatment. Patients and Methods: This is a parallel-group clinical study conducted on 64 patients divided into two groups; H2O2 group (n=32) and ZnSO4 group (n=32). Patients were evaluated clinically and by the dermoscope at the end of two, four and six weeks. Results: H2O2 group showed complete response (CR) in 81.3% of cases, while zinc sulphate group revealed CR in 34.4% of cases. There was a statistically significant higher proportion of “disappearance of dotted vessels and reddish gray / pale background plus appearance of normal skin markings” in H2O2 group vs. zinc sulphate group. There was a statistically significantly higher ratio of CR among those with facial lesions who received treatment by hydrogen peroxide. Conclusion: In the context of plane warts, hydrogen peroxide (30%) seemed to be an effective therapeutic modality with a higher satisfaction rate compared to 10% ZnSO4 with minimal complications.

Research topics

  • Skin Protection and Aging
  • Cutaneous Melanoma Detection and Management
  • Dermatologic Treatments and Research

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/ejhm.2023.328638

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.